Temedica from Munich and pharmaceutical company AbbVie are making their new app Tami available free of charge for patients with chronic inflammatory bowel disease. Around 400,000 people in Germany are affected by the disease. The lifestyle app is designed to help people with ulcerative colitis and Crohn’s disease to better manage their everyday lives and provides an insight into the personalized course of the disease, influencing factors and long-term development of the disease.
LINK